Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 508

1.

Temporomandibular pain in adolescents with a history of preterm birth.

Nilsson IM, Brogårdh-Roth S, Månsson J, Ekberg E.

J Oral Rehabil. 2019 Jul;46(7):589-596. doi: 10.1111/joor.12782. Epub 2019 Mar 20.

PMID:
30807654
2.

Focused breastfeeding counselling improves short- and long-term success in an early-discharge setting: A cluster-randomized study.

Nilsson IMS, Strandberg-Larsen K, Knight CH, Hansen AV, Kronborg H.

Matern Child Nutr. 2017 Oct;13(4). doi: 10.1111/mcn.12432. Epub 2017 Feb 14.

PMID:
28194877
3.

Early discharge following birth - What characterises mothers and newborns?

Nilsson IM, Kronborg H, Knight CH, Strandberg-Larsen K.

Sex Reprod Healthc. 2017 Mar;11:60-68. doi: 10.1016/j.srhc.2016.10.007. Epub 2016 Nov 1.

PMID:
28159130
4.

Treatment Seeking and Self-Constructed Explanations of Pain and Pain Management Strategies Among Adolescents with Temporomandibular Disorder Pain.

Nilsson IM, Willman A.

J Oral Facial Pain Headache. 2016 Spring;30(2):127-33. doi: 10.11607/ofph.1450.

PMID:
27128476
5.

Prevalence of temporomandibular disorder pain in Chinese adolescents compared to an age-matched Swedish population.

Hongxing L, Astrøm AN, List T, Nilsson IM, Johansson A.

J Oral Rehabil. 2016 Apr;43(4):241-8. doi: 10.1111/joor.12366. Epub 2015 Nov 5.

6.

Treating temporomandibular disorders in adolescents: a randomized, controlled, sequential comparison of relaxation training and occlusal appliance therapy.

Wahlund K, Nilsson IM, Larsson B.

J Oral Facial Pain Headache. 2015 Winter;29(1):41-50. doi: 10.11607/ofph.1285.

PMID:
25635959
7.

Validity and reliability of OIDP and OHIP-14: a survey of Chinese high school students.

Hongxing L, List T, Nilsson IM, Johansson A, Astrøm AN.

BMC Oral Health. 2014 Dec 19;14:158. doi: 10.1186/1472-6831-14-158.

8.

Headache and co-morbid pains associated with TMD pain in adolescents.

Nilsson IM, List T, Drangsholt M.

J Dent Res. 2013 Sep;92(9):802-7. doi: 10.1177/0022034513496255. Epub 2013 Jun 27.

PMID:
23813050
9.

Adolescents with temporomandibular disorder pain-the living with TMD pain phenomenon.

Nilsson IM, List T, Willman A.

J Orofac Pain. 2011 Spring;25(2):107-16.

PMID:
21528117
10.

Impact of temporomandibular disorder pain in adolescents: differences by age and gender.

Nilsson IM, Drangsholt M, List T.

J Orofac Pain. 2009 Spring;23(2):115-22.

PMID:
19492536
11.

Bereaved spouses' adjustment after the patients' death in palliative care.

Carlsson ME, Nilsson IM.

Palliat Support Care. 2007 Dec;5(4):397-404.

PMID:
18044417
12.

Incidence and temporal patterns of temporomandibular disorder pain among Swedish adolescents.

Nilsson IM, List T, Drangsholt M.

J Orofac Pain. 2007 Spring;21(2):127-32.

PMID:
17547124
13.
14.

The reliability and validity of self-reported temporomandibular disorder pain in adolescents.

Nilsson IM, List T, Drangsholt M.

J Orofac Pain. 2006 Spring;20(2):138-44.

PMID:
16708831
15.

Prevalence of temporomandibular pain and subsequent dental treatment in Swedish adolescents.

Nilsson IM, List T, Drangsholt M.

J Orofac Pain. 2005 Spring;19(2):144-50.

PMID:
15895837
16.

Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.

Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A.

J Infect Dis. 1999 Oct;180(4):1370-3.

PMID:
10479175
17.

Commentary to Erik von Willebrand's original paper from 1926 'Hereditär pseudohemofili'.

Nilsson IM.

Haemophilia. 1999 May;5(3):220-1. No abstract available.

PMID:
10444292
18.

Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis.

Deng GM, Nilsson IM, Verdrengh M, Collins LV, Tarkowski A.

Nat Med. 1999 Jun;5(6):702-5.

PMID:
10371511
19.

The history of von Willebrand disease.

Nilsson IM.

Haemophilia. 1999 May;5 Suppl 2:7-11. No abstract available.

PMID:
23401894
20.

Tolerance induction using the Malmö treatment model 1982-1995.

Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg B, Nilsson IM.

Haemophilia. 1999 Jan;5(1):32-9.

PMID:
10215945
21.

Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis.

Nilsson IM, Hartford O, Foster T, Tarkowski A.

Infect Immun. 1999 Mar;67(3):1045-9.

22.

Immunoadsorption for removal of inhibitors: update on treatments in Malmö-Lund between 1980 and 1995.

Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg BM, Nilsson IM.

Haemophilia. 1998 Jan;4(1):16-20.

PMID:
9873860
23.

Major surgery seems not to influence HIV disease progression in haemophilia patients.

Astermark J, Löfqvist T, Schulman S, Stigendal L, Lethagen S, Nilsson IM, Berntorp E.

Br J Haematol. 1998 Oct;103(1):10-4.

PMID:
9792282
24.

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death.

Nilsson IM, Patti JM, Bremell T, Höök M, Tarkowski A.

J Clin Invest. 1998 Jun 15;101(12):2640-9.

25.
26.

Radioactive synoviorthesis in patients with hemophilia with factor inhibitor.

Löfqvist T, Petersson C, Nilsson IM.

Clin Orthop Relat Res. 1997 Oct;(343):37-41.

PMID:
9345203
27.

The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.

Nilsson IM, Lee JC, Bremell T, Rydén C, Tarkowski A.

Infect Immun. 1997 Oct;65(10):4216-21.

28.

The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

Prescott R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, Hurst D, Bray G, Scandella D.

Blood. 1997 May 15;89(10):3663-71.

29.

Haemophilia prophylaxis in young patients--a long-term follow-up.

Löfqvist T, Nilsson IM, Berntorp E, Pettersson H.

J Intern Med. 1997 May;241(5):395-400.

30.

Orthopaedic surgery in hemophilia. 20 Years' experience in Sweden.

Löfqvist T, Nilsson IM, Petersson C.

Clin Orthop Relat Res. 1996 Nov;(332):232-41.

PMID:
8913168
31.

Role of the staphylococcal accessory gene regulator (sar) in septic arthritis.

Nilsson IM, Bremell T, Rydén C, Cheung AL, Tarkowski A.

Infect Immun. 1996 Nov;64(11):4438-43.

32.

[Threatened future of plasma products. Who is responsible?].

Berntorp E, Nilsson IM, Wollheim FA.

Lakartidningen. 1996 Oct 2;93(40):3443-4. Swedish. No abstract available.

PMID:
8926816
33.
34.

Total hip replacement in patients with hemophilia. 13 hips in 11 patients followed for 1-16 years.

Löfqvist T, Sanzén L, Petersson C, Nilsson IM.

Acta Orthop Scand. 1996 Aug;67(4):321-4.

PMID:
8792731
35.

Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations.

Berntorp E, Ekman M, Gunnarsson M, Nilsson IM.

Haemophilia. 1996 Apr;2(2):95-9. doi: 10.1111/j.1365-2516.1996.tb00022.x.

PMID:
27214015
36.
37.

Immune tolerance and the immune modulation protocol.

Berntorp E, Nilsson IM.

Vox Sang. 1996;70 Suppl 1:36-41. No abstract available.

PMID:
8869467
38.

Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model.

Nilsson IM, Berntorp E, Rickard KA.

Haemophilia. 1995 Jan;1(1):59-66. doi: 10.1111/j.1365-2516.1995.tb00041.x.

PMID:
27214223
39.

Apheresis.

Nilsson IM, Freiburghaus C.

Adv Exp Med Biol. 1995;386:175-84.

PMID:
8851026
40.

Tissue plasminogen activator, its fast acting plasma inhibitor and protein C after renal transplantation.

Brunkwall J, Bergqvist D, Almér LO, Nilsson IM.

Thromb Res. 1995 Jan 1;77(1):105-11. No abstract available.

PMID:
7701474
41.

Is haemophilia prophylaxis achievable in the context of self-sufficiency?

Nilsson IM.

Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S71-5.

PMID:
7795143
42.

Potency and in vivo recovery of high purity factor VIII concentrates.

Mikaelsson M, Oswaldsson U, Nilsson IM.

Thromb Haemost. 1994 Jul;72(1):160-1. No abstract available.

PMID:
7974366
43.

Factor VIII inhibitor treatment. Immune tolerance.

Nilsson IM.

Semin Hematol. 1994 Apr;31(2 Suppl 4):44-8. Review. No abstract available.

PMID:
7939775
44.

[Haemophilia--then and now].

Nilsson IM.

Sydsven Medicinhist Sallsk Arsskr. 1994;31:33-52. Swedish.

PMID:
11640407
45.

Biochemical and in vivo properties of high purity factor IX concentrates.

Berntorp E, Björkman S, Carlsson M, Lethagen S, Nilsson IM.

Thromb Haemost. 1993 Nov 15;70(5):768-73.

PMID:
8128433
46.

Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate.

Morfini M, Longo G, Berntorp E, Cinotti S, Filimberti E, Messori A, Nilsson IM, Rossi Ferrini P.

Thromb Res. 1993 Aug 1;71(3):175-84.

PMID:
8211885
47.

Experience with prophylaxis in Sweden.

Nilsson IM.

Semin Hematol. 1993 Jul;30(3 Suppl 2):16-9. No abstract available.

PMID:
8367738
48.

Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.

Donnér M, Kristoffersson AC, Berntorp E, Scheibel E, Thorsen S, Dahlbäck B, Nilsson IM, Holmberg L.

Eur J Haematol. 1993 Jul;51(1):38-44.

PMID:
8348943
49.

Treatment of patients with factor VIII and IX inhibitors.

Nilsson IM, Berntorp E, Freiburghaus C.

Thromb Haemost. 1993 Jul 1;70(1):56-9. Review. No abstract available.

PMID:
8236114
50.

Supplemental Content

Loading ...
Support Center